{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05361707",
            "orgStudyIdInfo": {
                "id": "VP-VEC-162-3601"
            },
            "organization": {
                "fullName": "Vanda Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances",
            "officialTitle": "A Study to Evaluate the Efficacy and Safety of Tasimelteon in Treating Sleep Disturbances in Individuals With Autism Spectrum Disorder",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluating-the-effects-of-tasimelteon-in-individuals-with-autism-spectrum-disorder-asd-and-sleep-disturbances"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-07-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-10-05",
            "studyFirstSubmitQcDate": "2022-04-29",
            "studyFirstPostDateStruct": {
                "date": "2022-05-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Vanda Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multicenter, open-label study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon in treating sleep disturbances in pediatric and adult participants with ASD."
        },
        "conditionsModule": {
            "conditions": [
                "Autism Spectrum Disorder",
                "Sleep Disorder",
                "Neurological Disorder",
                "Sleep Disturbance"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Tasimelteon",
                    "type": "EXPERIMENTAL",
                    "description": "Drug: Tasimelteon",
                    "interventionNames": [
                        "Drug: Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension",
                    "description": "Once Daily",
                    "armGroupLabels": [
                        "Tasimelteon"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in sleep time over the treatment period, as measured by sleep diary.",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Improvement in objective sleep-wake parameters such as severity of condition, as measured by administered questionnaires.",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Improvement in objective behavioral parameters such as the participant's overall behavior, as measured by sleep diary in the Patient Global Impression of Severity Behavior Questionnaire (PGI-S Behavior).",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Assessment of safety and tolerability of daily single dose of tasimelteon, as measured by spontaneous reporting of adverse events (AEs).",
                    "timeFrame": "12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Ability and acceptance to provide written informed consent of the participant or legal guardian (and assent as required).\n* A confirmed clinical diagnosis of Autism Spectrum Disorder (ASD) and a recent history of sleep disturbances.\n* The sleep disturbance must not be a result of another diagnosable disorder or medication.\n* Male or female between 2 and 65 years of age, inclusive.\n* Willing and able to comply with study requirements and restrictions.\n\nExclusion Criteria:\n\n* Inability to dose daily with tasimelteon or previous intolerance to tasimelteon.\n* Indication of impaired liver function.\n* Evidence of increased risk of self-harm.\n* Pregnant or lactating females.\n* A positive test for drugs of abuse.\n* Other diagnosable causes of sleep disorders or use of medications that may cause sedation or stimulation.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "2 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Vanda Pharmaceuticals Inc.",
                    "role": "CONTACT",
                    "phone": "202-734-3400",
                    "email": "VEC162@vandapharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "San Jose",
                    "state": "California",
                    "zip": "95124",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.33939,
                        "lon": -121.89496
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "San Leandro",
                    "state": "California",
                    "zip": "94578",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.72493,
                        "lon": -122.15608
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90404",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Boulder",
                    "state": "Colorado",
                    "zip": "80301",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.01499,
                        "lon": -105.27055
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "status": "RECRUITING",
                    "city": "Staten Island",
                    "state": "New York",
                    "zip": "10312",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.56233,
                        "lon": -74.13986
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012893",
                    "term": "Sleep Wake Disorders"
                },
                {
                    "id": "D000020447",
                    "term": "Parasomnias"
                },
                {
                    "id": "D000020920",
                    "term": "Dyssomnias"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000001321",
                    "term": "Autistic Disorder"
                },
                {
                    "id": "D000067877",
                    "term": "Autism Spectrum Disorder"
                },
                {
                    "id": "D000002659",
                    "term": "Child Development Disorders, Pervasive"
                }
            ],
            "ancestors": [
                {
                    "id": "D000065886",
                    "term": "Neurodevelopmental Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M22655",
                    "name": "Dyssomnias",
                    "asFound": "Sleep Disturbance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22242",
                    "name": "Parasomnias",
                    "asFound": "Sleep Disturbance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4623",
                    "name": "Autistic Disorder",
                    "asFound": "Autism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M206",
                    "name": "Autism Spectrum Disorder",
                    "asFound": "Autism Spectrum Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15696",
                    "name": "Sleep Wake Disorders",
                    "asFound": "Sleep Disorders",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5903",
                    "name": "Child Development Disorders, Pervasive",
                    "asFound": "Autism Spectrum Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5902",
                    "name": "Developmental Disabilities",
                    "relevance": "LOW"
                },
                {
                    "id": "M30644",
                    "name": "Neurodevelopmental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}